Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Exploring the Difficulties of Co-Nurturing: Individual Bits of knowledge - 2The risk of falling space junk hitting airplanes is on the rise, experts warn
- 31st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
- 4Storm Goretti sweeps United Kingdom, France with winds over 120 mph
- 5Astronomers spot white dwarf star creating a colorful shockwave
- First SpaceX booster for upgraded Starship fails during test in Texas
- The Best Computer games Ever
- 10 Moves toward Start Your Own Effective Business
- Nigeria police charge Joshua driver with dangerous driving over fatal crash
- Israel reports second missile fire from Yemen since start of Iran war
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Members of Kenya-led security mission in Haiti were involved in rapes, U.N. says
- ‘Risk children’s lives for some extra manpower’: IRGC recruits 12 year olds to fill personnel gaps
- Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated
